Inactive Instrument
Midatech Pharma PLC Stock Nasdaq
Stocks
US59564R1041
Biotechnology & Medical Research
| Market Cap | 913K 1.23M 1.07M 994K 1.72M 117M 1.75M 11.72M 4.6M 58.38M 4.61M 4.51M 196M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 913K 1.23M 1.07M 994K 1.72M 117M 1.75M 11.72M 4.6M 58.38M 4.61M 4.51M 196M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.38% |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 65 | 2020-03-30 |
Fiona Sharp
DFI | Director of Finance/CFO | 58 | 2026-01-04 |
Noreen Bhatti
CTO | Chief Tech/Sci/R&D Officer | - | 2024-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Sijmen de Vries
BRD | Director/Board Member | 67 | 2014-11-12 |
Simon Turton
BRD | Director/Board Member | 59 | 2014-12-11 |
Stephen Stamp
BRD | Director/Board Member | 65 | 2019-09-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | -20.98% | - | - | 121 | |
| +2.35% | +0.77% | +29.92% | +85.38% | 55.23B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.75B | |
| -1.92% | +1.78% | -15.43% | -16.49% | 23.48B | |
| -3.29% | -8.17% | -8.48% | +344.48% | 22B | |
| +2.49% | -1.27% | +15.99% | -10.53% | 19.78B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.44B | |
| +0.58% | -7.23% | +24.50% | +519.07% | 14.66B | |
| -4.52% | -3.57% | +47.42% | +170.90% | 14.07B | |
| +3.41% | -7.83% | +161.76% | +284.91% | 13.02B | |
| Average | +0.01% | -1.43% | +34.48% | +156.38% | 25.94B | |
| Weighted average by Cap. | +0.23% | +0.09% | +27.52% | +120.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
